Clinical Guideline Adaptation for Treatment of Neonatal Sepsis Based on Frequency of Microbial Agents

Document Type: Original Article

Authors

1 Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

2 School of Medicine, Department of Community and Family Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

3 School of Medicine, Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran

4 Neonatal Intensive Care Unit, Alzahra Teaching Hospital, Tabriz University of Medical Sciences, Tabriz, Iran

Abstract

Background: Sepsis is one of the most important causes of death in infants. The pattern of bacterial agents responsible for neonatal septicemia changes over time. The main aim of the present study was to provide a clinical guideline adapted for treatment of neonatal sepsis based on the frequency of microbial agents in the Neonatal Intensive Care Unit of Alzahra Hospital, Tabriz, Iran.
Methods: The clinical guideline adaptation is conducted based on the ADAPTE Resource Toolkit for Guideline Adaptation (version 2.0) from December 2016 to January 2018. For data collection, the specialized websites were identified, then an internet search method was used for gaining clinical guidelines and medical literature databases. A panel was established with members of multi-specialties and the obtained guidelines were examined and evaluated. In the end, the final guideline was selected and translated.
Results: Regarding the guideline, employing antibiotics should start when the neonate is < 35 weeks and premature rupture of membrane (PROM) happened < 18 h. Moreover, it could be employed when the neonate did not receive antibiotics, the gestational age (GA) is < 35 weeks with a PROM < 18 h or a GA < 37 weeks with a PROM ≥ 18 h. Conclusion: Implementation of the neonatal sepsis treatment guideline leads to a unified method of treatment, reduces the risk of antibiotic resistance, and decreases the mortality and morbidity associated with sepsis.


Keywords


1. Annette Enrione A, Powell KR. Sepsis, septic shock and systemic inflammatory response syndrome. In: Kleigman RM, Behrman RE, Jenson HB, Stanton BM, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: W.B. Saunders; 2008. P. 1094.
2. Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J. 2009; 28(1 Suppl):S10-8.
3. Nikpay S, YadegarAzadi A, Mohamadi J, Soleymani A, Badfar G. Epidemiologic Indicators of Neonatal Sepsis in Teaching Hospitals of Ilam, Western Iran during (2012-2017). Int J Pediatr. 2018; 6(7): 7947-58.
4. Li Z, Xiao Z, Li Z, Zhong Q, Zhang Y, Xu F. 116 cases of neonatal early-onset or late-onset sepsis: A single center retrospective analysis on pathogenic bacteria species distribution and antimicrobial susceptibility. Int J Clin Exp Med. 2013; 6(8):693-9.
5. Rafati MR, Farhadi R, Nemati-Hevelai E, Chabra A. Determination of frequency and antibiotic resistance of common bacteria in late onset sepsis at the neonatal ward in Booali-Sina Hospital of Sari, Iran. J Babol Univ Med Sci. 2014; 16(6):64-71.
6. Kliegman R, Behrman RE, Nelson WE. Nelson textbook of pediatrics. New York: Elsevier; 2016.
7. Dehghan K, Karimi S, Alilu L. The effect of probiotics on late-onset sepsis in very preterm infants: a randomized clinical trial. Int J Pediatr. 2018; 6(10):8371-9.
8. Sankar MJ, Agarwal R, Deorari AK, Paul VK. Sepsis in the newborn. Indian J Pediatr. 2008; 75(3):261-6.
9. Wu JH, Chen CY, Tsao PN, Hsieh WS, Chou HC. Neonatal sepsis: a 6-year analysis in a neonatal care unit in Taiwan. Pediatr Neonatol. 2009; 50(3):88-95.
10. You D, Hug L, Ejdemyr S, Idele P, Hogan D, Mathers C, et al. Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN inter-agency group for child mortality estimation. Lancet. 2015; 386(10010):2275-86.
11. Wang M, Wei H, Zhao Y, Shang L, Di L, Lyu C, Liu J. Analysis of multidrug-resistant bacteria in 3223 patients with hospital-acquired infections (HAI) from a tertiary general hospital in China. Bosnian J Basic Med Sci. 2019; 19(1):86-93.
12. Shehab El-Din EM, El-Sokkary MM, Bassiouny MR, Hassan R. Epidemiology of neonatal sepsis and implicated pathogens: a study from Egypt. Biomed Res Int. 2015; 2015:509484.
13. Khan SN, Joseph S. Neonatal sepsis: antibiotic sensitivity and resistance pattern of commonly isolated pathogens in a neonatal intensive care unit of a teritiary care hospital, South India. Int J Pharm Bio Sci. 2012; 3(4):802-9.
14. Edmond K, Zaidi A. New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med. 2010; 7(3):e1000213.
15. Afzalian N. Acute care of at-risk newborns (ACORN).
1st ed. Tehran: Publication of Fanohonar; 2011. P. 9-19.
16. Resch B, Müller W, Erwa W, Cimenti C, Hofer N, Griesmaier E. Neonatal bacterial infection. In: Tech C, editor. Neonatal bacterial infection. New York: Saunders Book Company; 2013. P. 11-23.
17. Stone L. Neonatal bacterial infection (eBook). New York: Hayle Medical; 2015. P. 53-6.
18. Clinical guideline adaptation. Urogynecology Knowledge Management of Iran. Available at: URL: https://ykmu.tbzmed.ac.ir; 2018.
19. Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012; 129(5):1006-15.
20. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease. Morbidity and Mortality Weekly Report (MMWR), Revised Guidelines from CDC. Recommend Rep. 2010; 59(RR10):1-32.
21. National Collaborating Centre for Women's and Children's Health (UK). Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection. London: RCOG Press; 2012.
22. Queensland Health. Queensland Maternity and Neonatal Clinical Guidelines Program. Early Onset Group B Streptococcal Disease: Queensland Maternity and Neonatal Clinical Guideline. New York: Queensland Health; 2011.
23. Muller-Pebody B, Johnson AP, Heath PT, Gilbert RE, Henderson KL, Sharland M, et al. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed. 2011; 96(1):F4-8.
24. Wilson CB, Nizet V, Maldonado Y, Klein JO, Remington JS. Remington and Klein's infectious diseases of the fetus and newborn infant. 8th ed. New York: Elsevier Health Science; 2015. P. 1048-53.
25. Mugglestone MA, Murphy MS, Visintin C, Howe DT, Turner MA. Antibiotics for early‐onset neonatal infection: a summary of the NICE guideline 2012. Obstet Gynaecol. 2014; 16(2):87-92.
26. Martin RJ, Fanaroff AA, Walsh MC. Perinatal and Neonatal care in developing countries. fanaroff and martin's neonatal-perinatal medicine: diseases of the fetus and infant. 10th ed. Philadelphia: Mosby Elsevier; 2015.
27. Mollarahimi MF, Nojoumi M, Biglari M, Ezoji K. Adaptation of preventive guideline of cardiovascular disease. Razi J Med Sci. 2017; 23(152):46-53.
28. Chu A, Hageman JR, Schreiber M, Alexander K. Antimicrobial therapy and late onset sepsis. NeoReviews. 2012; 13(2):e94-102.
29. Marchant EA, Boyce GK, Sadarangani M, Lavoie PM. Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol. 2013; 2013:586076.
30. Russell AR. Neonatal sepsis. Paediatr Child Health. 2015; 25(6):271-5 .
31. Bhat YR, Lewis LE, Vandana KE. Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India. Ital J Pediatr. 2011; 37:32.

32. Asgharisana F, Gaibi S. study of the role of common bacterial etiology in neonatal sepsis in Urumiah Shahid. N Cell Mol Biotechnol J. 2011; 1(3):17-21.
33. Nahar BS, Afroza S, Roy S, Nahar N, Kundu TN. Neonatal sepsis in a tertiary care hospital: evaluation of causative agents and antimicrobial susceptibilities. Bangladesh J Child Health. 2013; 37(1):14-7.